Abbvie Inc (NYSE:ABBV)

152.34 USD +2.89 USD ( +1.93% )

Watchlist Manager

Watchlist

ROIC
Return on Invested Capital

ROIC is a return ratio which expresses recurring operating profits as a percentage of the company’s net operational assets.

ROIC

NOPAT

Invested Capital

ROIC History

	1 Year	3 Years	5 Years
Average	13.7%	18.3%	17.2%
Median	13%	17.1%	14.3%
Min	12.4%	11.4%	11.4%
Max	17.1%	27.7%	27.7%

ROIC Across Competitors

Country	Company	Market Cap	ROIC
US	Abbvie Inc NYSE:ABBV	269B USD	13%
US	Amgen Inc NASDAQ:AMGN	131B USD	14%
AU	CSL Ltd ASX:CSL	128B AUD	17%
US	Gilead Sciences Inc NASDAQ:GILD	79.2B USD	13%
US	Vertex Pharmaceuticals Inc NASDAQ:VRTX	74.8B USD	44%
US	Regeneron Pharmaceuticals Inc NASDAQ:REGN	67.1B USD	49%

Country	US
Market Cap	269B USD

ROIC

13%

Country	US
Market Cap	131B USD

ROIC

14%

Country	AU
Market Cap	128B AUD

ROIC

17%

Country	US
Market Cap	79.2B USD

ROIC

13%

Country	US
Market Cap	74.8B USD

ROIC

44%

Country	US
Market Cap	67.1B USD

ROIC

49%

Profitability Report

View the profitability report to see the full profitability analysis for Abbvie Inc.

Full Profitability Report

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.